UnitedHealth’s strong first quarter and forecast cheers up Wall Street.

UnitedHealth opened the first quarter’s earnings season for insurers ⁠with ⁠a strong performance, raising its annual profit ⁠forecast and surpassing Wall Street expectations for quarterly earnings and revenue.

The upbeat results gave a ​boost to the shares of the conglomerate, which has faced a series of setbacks over the past two years, including a cyberattack ‌on its technology arm, rising medical costs ‌and the killing of its insurance unit chief, which sparked a public backlash against the industry.

Below are some comments from analysts ⁠and investors.

“Bottom line, margins are improving and further gains ​in profitability could be driven by continued AI deployment and restructuring. This is allowing for a new floor in earnings to feel stronger, adding more investor confidence going forward.”

“1Q26 results look nicely better than optimistic expectations, particularly with a nice MLR beat and sizeable ​Optum Health outperformance (earned nearly all of adjusted earnings for 2026 in 1Q26)... Good start to the year. It’s early, ⁠but ⁠a lot of embedded earnings within ⁠this business.”

“We believe this was a positive quarter for UNH. Highlighting the quarter was the beat on medical cost ​trend and the strong performance in ⁠Optum Health.” 

“While medical cost trends remain elevated, this remained in line with the company’s expectations, which we view as supportive of our belief that medical cost trend acceleration has peaked.” 

“Investors are likely showing signs of relief with this mornings premarket on UNH. The stock has had a volatile run over its last few earnings reports, ⁠largely dictated by surging medical costs in its Medicare Advantage business and regulatory shifts. While the stock ⁠has struggled for much of the past year, it is currently showing signs of a turnaround, or at least stability that investors are appreciating.” 

“Overall, results were strong, as UNH appears poised to return to its consistent beat-and-raise ways. We expect the stock to be strong on this release, which should also support the group.”

“we had expected guidance raises this year, but had thought Q2 was the more likely first raise. We assume the early raise is likely due to stronger MA performance and possibly improved reserve development from 2025 claims, which would suggest a better jump ⁠off point.” 

“Key questions to understand magnitude of full-year outperformance will be seasonality of MA related results and prior period development.” 

“On balance, we see this as a positive first step for UNH... While investors will want a better understanding of the cadence and dynamics at play at Optum, we think this print should broadly ​start MCO earnings off on the right foot.”